ஆஷிஷ் மகேஸ்வரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆஷிஷ் மகேஸ்வரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆஷிஷ் மகேஸ்வரி Today - Breaking & Trending Today

Affine's Accelerator Program 'Deep Camp' goes live

Bengaluru (Karnataka) [India], August 11 (ANI/PR Newswire): Affine, a leading AI consulting firm, goes live with its Accelerator Program, 'Deep Camp'. ....

Vineet Kumar , Ankit Agarwal , Aashish Maheshwari , Centers Of Excellence , Solutions Architect , Accelerator Program , Social Impact , Deep Camp , Chief Solutions Architect , Global Operations , Ai Consulting Firm , Accelerator Program , Start Ups , திராட்சை குமார் , அங்கித் அகர்வால் , ஆஷிஷ் மகேஸ்வரி , மையங்கள் ஆஃப் சிறப்பானது , தீர்வுகள் கட்டட வடிவமைப்பாளர் , முடுக்குப்பொறி ப்ரோக்ர்யாம் , சமூக தாக்கம் , ஆழமான முகாம் , தலைமை தீர்வுகள் கட்டட வடிவமைப்பாளர் , உலகளாவிய செயல்பாடுகள் ,

Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22

Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Andhra Pradesh , Dominican Republic , El Salvador , Central African Republic , Aashish Maheshwari , Balaxi Pharmaceuticals Ltd , Balaxi Pharmaceuticals , Share Of Pharmaceuticals , Prnewswire Balaxi Pharmaceuticals Limited , Pharmaceuticals Limited , Pharmaceutical Product , Import Permits , Managing Director , Business Overview , Consumer Business , Balaxi Pharmaceuticals Limited , Pharmaceuticals Ltd , Branded Consumer Products , ஆந்திரா பிரதேஷ் , டொமினிகன் குடியரசு , எல் சால்வடார் , ஆஷிஷ் மகேஸ்வரி , மருந்துகள் வரையறுக்கப்பட்டவை , மருந்து ப்ராடக்ட் , இறக்குமதி அனுமதிக்கிறது , நிர்வகித்தல் இயக்குனர் ,

Balaxi Pharma posts PAT of Rs 381 million for FY21

Balaxi Pharma posts PAT of Rs 381 million for FY21
Balaxi Pharma posts PAT of Rs 381 million for FY21
25 May 2021 | News
Registers EBITDA of Rs 100 million for Q4FY21
Balaxi Pharmaceuticals (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and year ended March 31, 2021.
The company recorded a revenue of Rs 530 million for Q4F21, the drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday. EBITDA of Rs 100 million for Q4FY21; EBITDA margin stood at 18.9 per cent. Reported PAT of Rs 84 million for Q4FY21. ....

Andhra Pradesh , Dominican Republic , Balaxi Pharma , Aashish Maheshwari , Balaxi Pharmaceuticals , Chinese New Year , Aashish Maheshwari , ஆந்திரா பிரதேஷ் , டொமினிகன் குடியரசு , ஆஷிஷ் மகேஸ்வரி , சீன புதியது ஆண்டு ,

Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline

Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline
HYDERABAD, India, May 24, 2021 /PRNewswire/ Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and year ended 31st March 2021.
Financial Highlights - Q4 & FY21:
16.5%
The Company recorded a revenue of INR 530 million for Q4F21, the drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday.
EBITDA of INR 100 million for Q4FY21; EBITDA margin stood at 18.9%.
Reported PAT of INR 84 million for Q4FY21. ....

United Arab Emirates , Andhra Pradesh , Dominican Republic , El Salvador , Central African Republic , Aashish Maheshwari , Subsidiary Of The Company , Balaxi Pharmaceuticals Ltd , Balaxi Pharmaceuticals , Share Of Pharmaceuticals , Prnewswire Balaxi Pharmaceuticals Limited , Pharmaceuticals Limited , Chinese New Year , Pharmaceutical Product , Import Permits , Managing Director , Business Overview , Owned Subsidiary , Balaxi Healthcare Honduras , Balaxi Pharmaceuticals Limited , Pharmaceuticals Ltd , Branded Consumer Products , Looking Statement , ஒன்றுபட்டது அரபு அமீரகங்கள் , ஆந்திரா பிரதேஷ் , டொமினிகன் குடியரசு ,

Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline

Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Arab Emirates , Andhra Pradesh , Dominican Republic , El Salvador , Central African Republic , Aashish Maheshwari , Subsidiary Of The Company , Balaxi Pharmaceuticals Ltd , Balaxi Pharmaceuticals , Share Of Pharmaceuticals , Prnewswire Balaxi Pharmaceuticals Limited , Pharmaceuticals Limited , Chinese New Year , Pharmaceutical Product , Import Permits , Managing Director , Business Overview , Owned Subsidiary , Balaxi Healthcare Honduras , Balaxi Pharmaceuticals Limited , Pharmaceuticals Ltd , Branded Consumer Products , ஒன்றுபட்டது அரபு அமீரகங்கள் , ஆந்திரா பிரதேஷ் , டொமினிகன் குடியரசு , எல் சால்வடார் ,